Synovitis Due to Osteoarthritis
Synovitis due to osteoarthritis represents a secondary inflammatory process within the synovial membrane triggered by mechanical and biochemical degeneration of articular cartilage. While osteoarthritis (OA)…
Synovial Sarcoma
Synovial sarcoma is a rare and aggressive soft tissue malignancy that arises from mesenchymal cells. Despite its name, it does not originate from synovial tissue…
Synergy for Streptococcal Endocarditis
Streptococcal endocarditis, a subset of infective endocarditis (IE), predominantly affects native heart valves and is most commonly caused by viridans group streptococci (VGS), Streptococcus bovis,…
Synergy for Staphylococcus aureus Pneumonia
Staphylococcus aureus pneumonia is a severe respiratory infection that frequently leads to complications such as necrotizing pneumonia, bacteremia, and respiratory failure. The prevalence of both…
Synergy for Staphylococcus Skin and Skin Structure Infection
Staphylococcus aureus, particularly methicillin-resistant Staphylococcus aureus (MRSA), is a leading cause of skin and skin structure infections (SSSIs), encompassing cellulitis, abscesses, wound infections, and impetigo.…
Synergy for Staphylococcal Septicemia
Staphylococcal septicemia, caused predominantly by Staphylococcus aureus, is a life-threatening bloodstream infection marked by rapid progression to sepsis, organ dysfunction, and high mortality rates. The…
Synergy for Staphylococcal Osteomyelitis
Staphylococcal osteomyelitis, particularly that caused by Staphylococcus aureus, remains a significant therapeutic challenge due to its ability to invade bone tissue, form biofilms, and persist…
Synergy for Staphylococcal Joint Infection
Staphylococcal joint infections, particularly those caused by Staphylococcus aureus, represent a significant clinical challenge due to their aggressive nature, potential for chronicity, and the emergence…
Synergistic Antibiotic Strategies for Staphylococcal Infections
Staphylococcal infections, primarily caused by Staphylococcus aureus and coagulase-negative staphylococci (CoNS), represent a significant global burden due to their capacity for virulence, biofilm formation, and…